Clinical Trial

Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH

Name: Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH — clinical trial record (NCT07513480)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Women with PCOS with high AMH randomly allocated into group A \& B.Cyproterone acetate plus ethinyl estradiol,metformin \& myoinositol in group A and Cyproterone acetate plus ethinyl estradiol \& metformin are given in group B.Then letrozole 5 mg day 2 to day 6 is given \& ovarian response is seen in day 12 for 3 subsequent 3 months .

Trial Details

NCT Number	NCT07513480
Lead Sponsor	Mst.Sumyara Khatun
Conditions	PCOS
Enrollment	68 participants
Start Date	2024-08-12
Primary Completion	2025-11-12 (estimated)
Study Completion	2026-02-20 (estimated)
Updated on ClinicalTrials.gov	2026-04-07